Cargando…
LH Pretreatment as a Novel Strategy for Poor Responders
Introduction. Poor response to ovarian stimulation is still a major problem in IVF. The study presents a new stimulation protocol evaluated in a suppopulation of very difficult young poor ovarian responders. Material and Methods. The study consists in two sections. The first includes data from a ran...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145542/ https://www.ncbi.nlm.nih.gov/pubmed/25197669 http://dx.doi.org/10.1155/2014/926172 |
_version_ | 1782332200603090944 |
---|---|
author | Ferraretti, Anna Pia Gianaroli, Luca Motrenko, Tatiana Feliciani, Elisabetta Tabanelli, Carla Magli, Maria Cristina |
author_facet | Ferraretti, Anna Pia Gianaroli, Luca Motrenko, Tatiana Feliciani, Elisabetta Tabanelli, Carla Magli, Maria Cristina |
author_sort | Ferraretti, Anna Pia |
collection | PubMed |
description | Introduction. Poor response to ovarian stimulation is still a major problem in IVF. The study presents a new stimulation protocol evaluated in a suppopulation of very difficult young poor ovarian responders. Material and Methods. The study consists in two sections. The first includes data from a randomized controlled study involving forty-three young patients with a poor ovarian response in at least two previous cycles (intended as cycle cancellation or with ≤3 collected oocytes). Patients were randomized in two groups: group A (control) received FSH (400 IU/day), while group B received the new stimulation protocol consisting in a sequential association of 150 IU r-LH for 4 days followed by 400 IU r-FSH/after downregulation with daily GnRh agonist. The second includes data from the overall results in 65 patients treated with the new protocol compared to their previous performance with conventional cycles (historical control). Results. Both in the RCT and in the historical control study, LH pretreatment was able to decrease the cancellation rate, to improve the in vitro performance, and to significantly increase the live birth rates. Conclusions. LH pretreatment improved oocyte quantity and quality in young repeated poor responders selected in accordance with the Bologna criteria. |
format | Online Article Text |
id | pubmed-4145542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-41455422014-09-07 LH Pretreatment as a Novel Strategy for Poor Responders Ferraretti, Anna Pia Gianaroli, Luca Motrenko, Tatiana Feliciani, Elisabetta Tabanelli, Carla Magli, Maria Cristina Biomed Res Int Clinical Study Introduction. Poor response to ovarian stimulation is still a major problem in IVF. The study presents a new stimulation protocol evaluated in a suppopulation of very difficult young poor ovarian responders. Material and Methods. The study consists in two sections. The first includes data from a randomized controlled study involving forty-three young patients with a poor ovarian response in at least two previous cycles (intended as cycle cancellation or with ≤3 collected oocytes). Patients were randomized in two groups: group A (control) received FSH (400 IU/day), while group B received the new stimulation protocol consisting in a sequential association of 150 IU r-LH for 4 days followed by 400 IU r-FSH/after downregulation with daily GnRh agonist. The second includes data from the overall results in 65 patients treated with the new protocol compared to their previous performance with conventional cycles (historical control). Results. Both in the RCT and in the historical control study, LH pretreatment was able to decrease the cancellation rate, to improve the in vitro performance, and to significantly increase the live birth rates. Conclusions. LH pretreatment improved oocyte quantity and quality in young repeated poor responders selected in accordance with the Bologna criteria. Hindawi Publishing Corporation 2014 2014-08-12 /pmc/articles/PMC4145542/ /pubmed/25197669 http://dx.doi.org/10.1155/2014/926172 Text en Copyright © 2014 Anna Pia Ferraretti et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Ferraretti, Anna Pia Gianaroli, Luca Motrenko, Tatiana Feliciani, Elisabetta Tabanelli, Carla Magli, Maria Cristina LH Pretreatment as a Novel Strategy for Poor Responders |
title | LH Pretreatment as a Novel Strategy for Poor Responders |
title_full | LH Pretreatment as a Novel Strategy for Poor Responders |
title_fullStr | LH Pretreatment as a Novel Strategy for Poor Responders |
title_full_unstemmed | LH Pretreatment as a Novel Strategy for Poor Responders |
title_short | LH Pretreatment as a Novel Strategy for Poor Responders |
title_sort | lh pretreatment as a novel strategy for poor responders |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145542/ https://www.ncbi.nlm.nih.gov/pubmed/25197669 http://dx.doi.org/10.1155/2014/926172 |
work_keys_str_mv | AT ferrarettiannapia lhpretreatmentasanovelstrategyforpoorresponders AT gianaroliluca lhpretreatmentasanovelstrategyforpoorresponders AT motrenkotatiana lhpretreatmentasanovelstrategyforpoorresponders AT felicianielisabetta lhpretreatmentasanovelstrategyforpoorresponders AT tabanellicarla lhpretreatmentasanovelstrategyforpoorresponders AT maglimariacristina lhpretreatmentasanovelstrategyforpoorresponders |